?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
Biosimilars 101
Policies
Biosimilars are a Free-Market Solution
The Biosimilar Access and Affordability Act
News
Resources
signalgroup
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
Member Spotlight
September 3, 2026
signalgroup
Gillian Woollett Member Spotlight
Member Spotlight
August 24, 2026
signalgroup
Andrew Zacher Member Spotlight
News
July 24, 2026
signalgroup
The Biosimilars Forum Commends Members of the Senate HELP Committee for Supporting Lower-Cost Biosimilars
News
July 23, 2026
signalgroup
The Biosimilars Forum Commends Members of the House of Representatives Energy & Commerce Committee for Supporting Lower-Cost Biosimilars
News
April 23, 2026
signalgroup
The Biosimilars Forum Commends Governor Spanberger for Supporting Lower-Cost Medicines in Virginia
News
February 26, 2026
signalgroup
New Report by IQVIA Institute for Human Data Science Outlines ASP Policies to Support Prescription Drug Affordability and Lower-Cost Biosimilars
News
February 6, 2026
signalgroup
The Biosimilars Forum Applauds the FTC for Requiring PBMs to Increase Transparency and Lower Prescription Drug Prices
News
February 4, 2026
signalgroup
The Biosimilars Forum Applauds the Trump Administration and Members of Congress for Lowering Prescription Drug Prices through PBM Reform
News
December 10, 2025
signalgroup
Biosimilars Forum Calls for Congress to Pass the Skinny Labels, Big Savings Act to Support Safe, Effective and Lower-Cost Biosimilars
News
October 29, 2025
signalgroup
Biosimilars Forum Applauds FDA Commissioner Dr. Marty Makary for Supporting Safe, Effective and Lower-Cost Biosimilars
01
02
03
Next page